News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
65 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22291)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2475)
Day
1 (65)
3 (19)
4 (205)
5 (197)
6 (190)
7 (229)
8 (170)
10 (33)
11 (150)
12 (194)
13 (208)
14 (261)
15 (58)
17 (52)
18 (160)
19 (145)
20 (146)
21 (119)
22 (102)
24 (37)
25 (10)
26 (177)
27 (191)
28 (158)
29 (79)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
1
3
4
5
6
7
8
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
31
Press Releases
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
May 1, 2026
·
4 min read
Press Releases
TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer
May 1, 2026
·
15 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
·
4 min read
Press Releases
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
May 1, 2026
·
14 min read
Press Releases
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
May 1, 2026
·
9 min read
Press Releases
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 1, 2026
·
13 min read
Press Releases
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
May 1, 2026
·
1 min read
Press Releases
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health
May 1, 2026
·
2 min read
Approvals
Axsome wins first non-antipsychotic FDA approval for Alzheimer’s agitation
Alzheimer’s disease agitation could mean peak sales of over $2.1 billion for Axsome’s Auvelity, according to analysts at William Blair.
May 1, 2026
·
2 min read
·
Tristan Manalac
Neurodegenerative disease
Corcept ties ALS drug to improved 2-year survival as Phase 3 start date nears
Corcept Therapeutics’ amyotrophic lateral sclerosis drug was linked to an 87% reduction in the risk of death, a result the biotech hopes to replicate in an upcoming Phase 3 trial.
May 1, 2026
·
2 min read
·
Nick Paul Taylor
Previous
3 of 7
Next
